Abstract

IntroductionDostarlimab+carboplatin-paclitaxel demonstrated PFS and OS benefits vs carboplatin-paclitaxel in patients with primary advanced or recurrent endometrial cancer (pA/rEC). Here, we report on the management of immune-related adverse events (irAEs) in...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
639 Management of immune-related adverse events in patients with primary advanced or recurrent endometrial cancer: dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial
Zoltán Novák ... Jørn Herrstedt
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. 34
Zoltán Novák, et. al.Zoltán Novák ... Jørn Herrstedt
01 Mar 2024
Decision-making preferences in patients with advanced and recurrent endometrial cancer (502)
Sarah Ackroyd ... Fay Hlubocky
Gynecologic oncology | VOL. 166
Sarah Ackroyd, et. al.Sarah Ackroyd ... Fay Hlubocky
01 Aug 2022
625 Dostarlimab + chemotherapy for the treatment of primary advanced or recurrent endometrial cancer: analysis of progression-free survival and overall survival outcomes by molecular classification in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial
Mansoor Raza Mirza ... Michael G Teneriello
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. 34
Mansoor Raza Mirza, et. al.Mansoor Raza Mirza ... Michael G Teneriello
01 Mar 2024
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.
Julie R Brahmer ...
Journal of Clinical Oncology | VOL. 36
Julie R Brahmer, et. al.Julie R Brahmer ...
14 Feb 2018
View more papers

More From: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Paper Title
Journal
Date
Author
Robotic staging for early ovarian cancer in 10 steps
Aniello Foresta ... Valerio Gallotta
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Aniello Foresta, et. al.Aniello Foresta ... Valerio Gallotta
01 Jul 2024
Measuring the impact of specific surgical complications after ovarian cancer cytoreductive surgery on short-term outcomes
Arwa Mohammad ... William Cliby
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Arwa Mohammad, et. al.Arwa Mohammad ... William Cliby
01 Jul 2024
Diagnostic performance of ultrasonography in pre-operative assessment of lymph nodes in patients with cervical cancer
Filip Fruhauf ... Daniela Fischerova
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. 34
Filip Fruhauf, et. al.Filip Fruhauf ... Daniela Fischerova
01 Jul 2024
Molecular classification of endometrial carcinoma on endometrial biopsy: an early prognostic value to guide personalized treatment
Stefano Restaino ... Giuseppe Vizzielli
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Stefano Restaino, et. al.Stefano Restaino ... Giuseppe Vizzielli
01 Jul 2024
View more papers